Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

NCT00080080 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00118131 ·Status: TERMINATED ·Phase: PHASE2

Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00301808 ·Status: COMPLETED ·Phase: PHASE2

Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00041054 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer

NCT00005868 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery

NCT00281970 ·Status: COMPLETED ·Phase: PHASE2

Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00003299 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

NCT00271323 ·Status: TERMINATED ·Phase: PHASE2

Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)

NCT00995761 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer

NCT00095199 ·Status: COMPLETED ·Phase: PHASE3

Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)

NCT00356122 ·Status: COMPLETED ·Phase: PHASE2

Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC

NCT00238615 ·Status: TERMINATED ·Phase: PHASE2

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00729612 ·Status: COMPLETED ·Phase: PHASE2

Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer

NCT00003281 ·Status: COMPLETED ·Phase: PHASE2

Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)

NCT04367311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

NCT01497041 ·Status: UNKNOWN ·Phase: PHASE2

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer

NCT00045162 ·Status: COMPLETED ·Phase: PHASE3

Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel

NCT01222312 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

NCT02504489 ·Status: COMPLETED ·Phase: PHASE3

Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571

NCT02127372 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

NCT00254384 ·Status: COMPLETED ·Phase: PHASE1

CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer

NCT03370159 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer

NCT00049790 ·Status: COMPLETED ·Phase: PHASE2

A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer

NCT00738387 ·Status: TERMINATED ·Phase: PHASE3

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

NCT00216125 ·Status: COMPLETED ·Phase: PHASE3